{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:54:15Z","timestamp":1791118455619,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/pas.0b013e318165b0d6","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T21:00:51Z","timestamp":1236286851000},"page":"1252-1257","source":"Crossref","is-referenced-by-count":112,"title":["PD-1, a Follicular T-cell Marker Useful for Recognizing Nodular Lymphocyte-predominant Hodgkin Lymphoma"],"prefix":"10.1097","volume":"32","author":[{"given":"Syong H.","family":"Nam-Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Sanchez-Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Dom\u00ednguez-Franjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/35018581","article-title":"A chemokine-driven positive feedback loop organizes lymphoid follicles","volume":"406","author":"Ansel","year":"2000","journal-title":"Nature"},{"key":"R2-18-20210131","first-page":"1294","article-title":"Follicular Hodgkin's disease","volume":"19","author":"Ashton-Key","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R3-18-20210131","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"R4-18-20210131","first-page":"1644","article-title":"Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma","volume":"63","author":"Br\u00e4uninger","year":"2003","journal-title":"Cancer Res"},{"key":"R5-18-20210131","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J Immunol"},{"key":"R6-18-20210131","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R7-18-20210131","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"key":"R8-18-20210131","first-page":"351","article-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours","author":"Jaffe","year":"2001"},{"key":"R9-18-20210131","first-page":"541","article-title":"Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma","volume":"142","author":"Kamel","year":"1993","journal-title":"Am J Pathol"},{"key":"R10-18-20210131","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00000478-200008000-00004","article-title":"Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis","volume":"24","author":"Kraus","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R11-18-20210131","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2559.2004.01878.x","article-title":"The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease","volume":"44","author":"Lin","year":"2004","journal-title":"Histopathology"},{"key":"R12-18-20210131","first-page":"957","article-title":"Leukocyte-specific phosphoprotein-1 and PU. 1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease","volume":"89","author":"Marafioti","year":"2004","journal-title":"Haematologica"},{"key":"R13-18-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000478-199901000-00003","article-title":"Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study","volume":"23","author":"Nguyen","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R14-18-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2004-04-1596","article-title":"The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation","volume":"105","author":"Riley","year":"2005","journal-title":"Blood"},{"key":"R15-18-20210131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.pas.0000149689.75462.ff","article-title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas","volume":"29","author":"Rodig","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R16-18-20210131","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3324\/haematol.10864","article-title":"Expression of two markers of germinal center T cell (SAP and PD-1) in angioimmunoblastic T-cell lymphoma","volume":"92","author":"Roncador","year":"2007","journal-title":"Haematologica"},{"key":"R17-18-20210131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/002215549704500301","article-title":"Antigen retrieval immunohistochemistry: past, present, and future","volume":"45","author":"Shi","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"R18-18-20210131","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1200\/JCO.2005.17.970","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials","volume":"23","author":"Shimabukuro-Vornhagen","year":"2005","journal-title":"J Clin Oncol"},{"key":"R19-18-20210131","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2002-05-1576","article-title":"Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma","volume":"101","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"R20-18-20210131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00129039-200409000-00005","article-title":"Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma","volume":"12","author":"Xiao","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R21-18-20210131","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-200808000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:02:57Z","timestamp":1618038177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200808000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e318165b0d6","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}